Incidence of macrosomia in Mexico: National and subnational estimations

PLoS One. 2022 Dec 2;17(12):e0276518. doi: 10.1371/journal.pone.0276518. eCollection 2022.

Abstract

Fetal macrosomia (FM) is a condition with adverse consequences for both mother and offspring. The occurrence of this condition has increased worldwide. The objectives of this study were: (1) to estimate the incidence of FM at the national and state levels in Mexico in 2020; (2) to estimate the incidence of FM stratified by maternal and newborn characteristics; (3) to identify the states with the highest risk of FM; (4) to georeference the incidence of FM. Open data from the Birth Information Subsystem were used. Relative risks were estimated by adjusted Poisson regression models. The national incidence of FM was 2.75%. The entity with the lowest incidence was Mexico City (1.28%) and the most affected states were Sonora (6.20%), Baja California Sur (5.44%), and Sinaloa (5.36%), located in the north of the country. The incidence of FM at the national level is below that reported in the international literature. The results of this study can be used for the design and implementation of programs, public policies, and interventions.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Female
  • Fetal Macrosomia* / epidemiology
  • Humans
  • Incidence
  • Infant, Newborn
  • Mexico / epidemiology
  • Mothers
  • Weight Gain*

Grants and funding

This work was supported by the Program of Summer Research 2021 “Fondo S.N.I. 100” of the Universidad Iberoamericana. Dr. Monica Ancira-Moreno is the recipient of the funding.